CEO of VIVUS.“By leveraging UpScriptHealth's expertise, within just a few clicks patients can now access medications, like QSYMIA, and consult with a physician from anywhere, ensuring that ...

QSYMIA is now approved and available in the United States, South Korea, Sweden, Norway, Poland, Denmark, Iceland, and Finland. The product was recently approved in United Arab Emirates and VIVUS ...

Collaborative telehealth platform will provide patients with immediate access to QSYMIA®, a chronic weight loss medication, enhancing their ...

QSYMIA is now approved and available in the United States, South Korea, Sweden, Norway, Poland, Denmark, Iceland, and Finland. The product was recently approved in United Arab Emirates and VIVUS is ...

VIVUS announced today that the U.S. Food and Drug Administration has removed the requirement for a cardiovascular outcome trial for its weight-management medication QSYMIA (phentermine and ...

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...

CAMPBELL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- VIVUS announced today that the U.S. Food and Drug Administration has removed the requirement for a cardiovascular outcome trial for its ...